Fig 4. Epistaxis severity score variation during bevacizumab treatment.
Baseline score represents epistaxis severity 3 months before starting bevacizumab treatment. The dotted line is the fitted regression line (Linear mixed effects model).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.